3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Sarcoma, Ewing
3
Rhabdomyosarcoma
3
Neuroblastoma
3
Brain Neoplasms
3
Wilms Tumor
2
Testicular Neoplasms
2
Sarcoma
2
Medulloblastoma
2
Central Nervous System Neoplasms
2
Astrocytoma
2
Waldenstrom Macroglobulinemia
1
Teratoma
1
Retinoblastoma
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Ovarian Germ Cell Cancer
1
Osteosarcoma
1
Optic Nerve Glioma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroectodermal Tumors
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Interventions
Ifosfamide
30
Methotrexate
29
Doxorubicin
26
Cyclophosphamide
24
Cisplatin
22
Filgrastim
18
Etoposide
17
Gemcitabine
16
Leucovorin
14
Magnetic Resonance Spectroscopy
11
Temozolomide
10
Specimen Handling
10
cabozantinib
9
apatinib
9
X-Rays
9
Carboplatin
9
fludarabine
8
Radiotherapy
8
Nivolumab
8
Neoadjuvant Therapy
8
Irinotecan
8
Granulocyte Colony-Stimulating Factor
8
Drug Therapy
8
Docetaxel
8
Zoledronic Acid
7
Vincristine
7
Sirolimus
7
Phantoms, Imaging
7
Biopsy
7
mifamurtide
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Bone Marrow Transplantation
×
Sarcoma
×
Clear all
NCT02100891
2025-03-19
STIR
Medical College of Wisconsin
Phase 2
Terminated
15 enrolled
11 charts